David M. Knott Jr’s Catalyst Pharmaceutical CPRX Stock Holding History

David M. Knott Jr’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.97M	Sell	120,000 -69,000	-37%	-$1.64M	1.77%	18
2025 Q4	$4.41M	Hold	189,000	–	–	2.04%	12
2025 Q3	$3.72M	Buy	189,000 +13,000	+7%	+$267K	1.56%	16
2025 Q2	$3.82M	Sell	176,000 -36,000	-17%	-$850K	1.73%	11
2025 Q1	$5.14M	Buy	212,000 +2,000	+1%	+$45K	2.43%	10
2024 Q4	$4.38M	Sell	210,000 -2,000	-0.9%	-$43K	1.58%	11
2024 Q3	$4.21M	Hold	212,000	–	–	1.48%	18
2024 Q2	$3.28M	Buy	212,000 +24,148	+13%	+$376K	1.31%	15
2024 Q1	$2.99M	Buy	187,852 +62,402	+50%	+$940K	1.06%	19
2023 Q4	$2.11M	Buy	+125,450	New	+$1.71M	0.81%	22

Other funds holding CPRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM